A greater understanding of the NF-κB-dependent transcriptional response and target protein synthesis in an NSCLC cell line following exposure to clinically relevant high-LET radiation in chronically hypoxic cells may contribute toward the optimization of radiotherapy options in NSCLC. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.